Matt Zeller is the Country President of Australia and New Zealand for Novartis. His previous roles with Novartis include Country President of the Europe Central Cluster and the Hungarian organization, Executive Director of US CV National Hospital accounts, VP and Head of US Patient and Specialty Services, US Sales and Marketing Head of the COPD franchise, and Director of Global Pharma Strategy in Switzerland. Prior to joining Novartis, Matt was a Principal in BCG’s New Jersey and Shanghai offices in the commercial pharma space focused on commercial transformation and go-to market/brand turnaround strategies. Prior to BCG, he worked in hospital marketing, pharma sales for Lilly, undertook non-profit work in Argentina, and briefly played professional baseball. Matt holds a Bachelor of Science from Vanderbilt University and an MBA from Duke University.
Country President Australia & New Zealand, Novartis
Matt Zeller
COVID-19 SAFE GUIDELINES
The Pharmacy Guild of Australia is committed to the health and safety of symposium delegates. In order to protect delegates from the spread of COVID-19 and to take into account Stage 3 Queensland Government restrictions, the following measures will be put in place:
1. Personal safety – each delegate will be provided with a pack containing hand sanitizer, disinfectant wipes and a mask. In addition to this, the venue will conduct regular cleaning of the venue spaces and equipment. Sanitation stations will also be available throughout the venue.
2. Physical distancing – session seating will be set up to follow the 4 square metres per person rule. Social functions will also comply with these rules.
3. Adherence to the COVID Safe Event Checklist – this is for events of up to 500 people and addresses the risks associated with the potential transmission of COVID-19.
Events Division – The Pharmacy Guild of Australia, Queensland Branch
132 Leichhardt St, Spring Hill QLD 4000
Ph: 07 3831 3788
Fax: 07 3831 9246
Email: events@qldguild.org.au